The blood-based test will use a 23-gene expression signature identified by researchers at VIB-KU Leuven and their collaborators.
The test will use plasmonics to detect DNA, microRNA, and tumor antibodies with high sensitivity within a single test.
The firm said that the test may be validated as a prognostic test for colorectal cancer and a predictive test for cancer immunotherapies.
Dr Risch Medical Laboratory will distribute the firm's PCR-based colorectal cancer blood test in the Swiss German market and Lichtenstein.
The company believes Indian clinicians and patients will be receptive to this new technology, but only in an efficient and actionable form.
Laboratoire Cerba was granted the right to develop a tumor expression test based on IntegraGen's proprietary microRNA biomarker.
Researchers showed in a new study that patterns of methylation co-occuring at different sites could help distinguish cancer DNA in the blood, and mark its original source in body.
VA patients will now have access to Polymedco's colorectal cancer screening products, including the Epigenomics Epi proColon.
The test kit runs on standard qPCR platforms in under three hours, and detects 20 cancer-associated biomarkers from four oncogenes.
The firm will apply the proceeds towards an early-stage clinical trial of a precision colorectal cancer vaccine.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.
Some science companies will be taking part in next month's March for Science, Fortune reports.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.